


To provide capital appreciation, investing in an actively managed portfolio of mainly European equities.
| Name | % Net Assets |
|---|---|
| TOTAL S.A | 4.0% |
| NOVARTIS AG | 3.9% |
| ROCHE HLDG AG | 2.9% |
| SANOFI-AVENTIS | 2.8% |
| FRANCE TELECOM | 2.8% |
| NESTLE SA | 2.6% |
| TELEFONICA SA | 2.3% |
| VIVENDI | 2.2% |
| E.ON AG | 1.8% |
| KONINKLIJKE AHOLD NV | 1.8% |
| Key | % Net Assets |
|---|---|
| 4.0% | |
| 3.9% | |
| 2.9% | |
| 2.8% | |
| 86.4% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 01/03/2004 |
|---|---|
| Fund Manager | Acadian / Clay Finlay |
| TER | 1.99 (30-Sep-2009) |
| Minimum Investment | |
|---|---|
| Initial | 500 |
| Additional | n/a |
| Savings | 50 |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.85% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.08 |
You are here: research